Piceatannol (Nano Biotherapeutics)

N/A

Report date: 2025/01/26 15:47:07

Base Information

Drug NamePiceatannol (Nano Biotherapeutics)
Drug Alias NameHLS13-13 (Cell Biologics)Piceatannol (Cell Biologics)
ClassificationBiologics
Mechanisms of ActionNeutrophil adhesion modulators
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCell Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNano Biotherapeutics, Inc
Inactive CompaniesCell Biologics Inc
Active IndicationsRespiratory Distress Syndrome, AdultAcute Lung Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A